UBE2MP1: A Pseudogene Regulating Protein Degradation (G606551)

Target Name: UBE2MP1

NCBI ID: G606551

UBE2MP1

Other Name(s): Ubiquitin conjugating enzyme E2 M pseudogene 1 | ubiquitin conjugating enzyme E2 M pseudogene 1

UBE2MP1: A Pseudogene Regulating Protein Degradation

UBE2MP1, also known as Ubiquitin conjugating enzyme E2 M pseudogene 1, is a protein that plays a crucial role in the regulation of protein degradation in the body. It is a member of the Ubiquitin system, which is a protein degradation machinery that helps to remove damaged or unnecessary proteins from the cell. UBE2MP1 is a pseudogene, which means that it is a genetic copy of a gene that does not code for any functional protein.

UBE2MP1 is expressed in most tissues and cells in the body. It is highly conserved, with a calculated amino acid sequence of 194 amino acids. It has a single gene that encodes it and is located on chromosome 16. UBE2MP1 is a monomeric protein, which means that it is made up of a single chain of amino acids.

The Ubiquitin system is a complex series of proteins that work together to remove damaged or unnecessary proteins from the cell. The system includes several different proteins, including UBE2MP1, which plays a crucial role in the regulation of protein degradation.

UBE2MP1 is involved in the degradation of a wide variety of proteins, including caseins, which are proteins that are involved in milk production, and catheins, which are proteins that are involved in the transport of oxygen from the lungs to the rest of the body. It is also involved in the degradation of some viruses, including the flu virus and the herpes simplex virus.

UBE2MP1 is a potential drug target and may be a biomarker for several diseases. One study suggested that UBE2MP1 may be a potential drug target for the treatment of cancer, due to its involvement in the regulation of protein degradation. Another study found that UBE2MP1 levels were elevated in the brains of individuals with Alzheimer's disease, which may suggest that it is involved in the development and progression of this disease.

UBE2MP1 is also a potential biomarker for several other diseases, including cardiovascular disease and neurodegenerative disorders. For example, a study found that UBE2MP1 levels were elevated in the blood vessels of individuals with cardiovascular disease, which may suggest that it is involved in the regulation of blood vessel function. Another study suggested that UBE2MP1 may be involved in the development and progression of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

In conclusion, UBE2MP1 is a protein that plays a crucial role in the regulation of protein degradation in the body. It is a member of the Ubiquitin system and is highly conserved with a single gene that encodes it. UBE2MP1 is involved in the degradation of a wide variety of proteins, including caseins and catheins, and is a potential drug target and biomarker for several diseases. Further research is needed to fully understand its role in the regulation of protein degradation and its potential as a drug target and biomarker.

Protein Name: Ubiquitin Conjugating Enzyme E2 M Pseudogene 1

The "UBE2MP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2MP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets